Abstract:Background: Two acute respiratory distress syndrome (ARDS) subphenotypes (hyperinflammatory and hypoinflammatory) with distinct clinical and biological features and differential treatment responses have been identified using latent class analysis (LCA) in seven individual cohorts. To facilitate bedside identification of subphenotypes, clinical classifier models using readily available clinical variables have been described in four randomised controlled trials. We aimed to assess the performance of these models in observational cohorts of ARDS. Methods: In this observational, multicohort, retrospective study, we validated two machine-learning clinical classifier models for assigning ARDS subphenotypes in two observational cohorts of patients with ARDS: Early Assessment of Renal and Lung Injury (EARLI; n=335) and Validating Acute Lung Injury Markers for Diagnosis (VALID; n=452), with LCA-derived subphenotypes as the gold standard. The primary model comprised only vital signs and laboratory variables, and the secondary model comprised all predictors in the primary model, with the addition of ventilatory variables and demographics. Model performance was assessed by calculating the area under the receiver operating characteristic curve (AUC) and calibration plots, and assigning subphenotypes using a probability cutoff value of 0·5 to determine sensitivity, specificity, and accuracy of the assignments. We also assessed the performance of the primary model in EARLI using data automatically extracted from an electronic health record (EHR; EHR-derived EARLI cohort). In Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE; n=2813), a multinational, observational ARDS cohort, we applied a custom classifier model (with fewer variables than the primary model) to determine the prognostic value of the subphenotypes and tested their interaction with the positive end-expiratory pressure (PEEP) strategy, with 90-day mortality as the dependent variable. Findings: The primary clinical classifier model had an area under receiver operating characteristic curve (AUC) of 0·92 (95% CI 0·90-0·95) in EARLI and 0·88 (0·84-0·91) in VALID. Performance of the primary model was similar when using exclusively EHR-derived predictors compared with manually curated predictors (AUC=0·88 [95% CI 0·81-0·94] vs 0·92 [0·88-0·97]). In LUNG SAFE, 90-day mortality was higher in patients assigned the hyperinflammatory subphenotype than in those with the hypoinflammatory phenotype (414 [57%] of 725 vs 694 [33%] of 2088; p<0·0001). There was a significant treatment interaction with PEEP strategy and ARDS subphenotype (p=0·041), with lower 90-day mortality in the high PEEP group of patients with the hyperinflammatory subphenotype (hyperinflammatory subphenotype: 169 [54%] of 313 patients in the high PEEP group vs 127 [62%] of 205 patients in the low PEEP group; hypoinflammatory subphenotype: 231 [34%] of 675 patients in the high PEEP group vs 233 [32%] of 734 patients in the low PEEP group). Interpretation: Classifier models using clinical variables alone can accurately assign ARDS subphenotypes in observational cohorts. Application of these models can provide valuable prognostic information and could inform management strategies for personalised treatment, including application of PEEP, once prospectively validated. Funding: US National Institutes of Health and European Society of Intensive Care Medicine.

Novel criteria to classify ARDS severity using a machine learning approach

Early predictive values of clinical assessments for ARDS mortality: a machine-learning approach

Positive end-expiratory pressure selection by comprehensively considering clinical measurements and patient characteristics may improve ICU outcome in ARDS patients: an observational study

Prediction Model for Critically Ill Patients with Acute Respiratory Distress Syndrome

Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis

Prediction Model for Patients with Acute Respiratory Distress Syndrome: Use of a Genetic Algorithm to Develop a Neural Network Model

Identification of Three Classes of Acute Respiratory Distress Syndrome Using Latent Class Analysis

Clinical phenotype of ARDS based on K-means cluster analysis: A study from the eICU database

[Progression in the application of machine learning in acute respiratory distress syndrome]

Analytics with Artificial Intelligence to Advance the Treatment of Acute Respiratory Distress Syndrome

Accuracy of the Radiographic Assessment of Lung Edema Score for the Diagnosis of ARDS

Individualized Mechanical Power-Based Ventilation Strategy for Acute Respiratory Failure Formalized by Finite Mixture Modeling and Dynamic Treatment Regimen

Establishment and Validation of Predictive Model of ARDS in critically ill patients

Predicting Duration of Mechanical Ventilation in Acute Respiratory Distress Syndrome Using Supervised Machine Learning

Oxygenation Index, Oxygen Saturation Index vs PaO2/FiO2 *PEEP: A Secondary Analysis of OXIVA-CARDS Study

Using machine learning for the early prediction of sepsis-associated ARDS in the ICU and identification of clinical phenotypes with differential responses to treatment

Open-source machine learning pipeline automatically flags instances of acute respiratory distress syndrome from electronic health records

Longitudinal analysis of ARDS variability and biomarker predictive power in burn patients

Decision support tool for differential diagnosis of Acute Respiratory Distress Syndrome (ARDS) vs Cardiogenic Pulmonary Edema (CPE): a prospective validation and meta-analysis

Identification of four latent classes of acute respiratory distress syndrome using PaO2/FIO2 ratio: an observational cohort study

A Retrospective, Nested Case-Control Study to Develop a Biomarker-Based Model for ARDS Diagnostics